Publications

5802 Results

Phase II study of fludarabine phosphate in previously untreatedpatients with colorectal carcinoma: A Southwest Oncology Group study.

Authors
WH Harvey;TR Fleming;DD Von Hoff;JG Katterhagen;C Coltman, Jr
Journal / Conference
Cancer Treat Rep 71(12):1319-1320
Year
1987
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8386

Phase II trial of fludarabine phosphate in patients with head andneck cancer: A Southwest Oncology Group Study.

Authors
GB Weiss;B Metch;DD Von Hoff;SA Taylor;JH Saiers
Journal / Conference
Cancer Treat Rep 71(12):1313-1314
Year
1987
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8403

Southwest Oncology Group clinical trials for intermediate andhigh-grade non-hodgkin's lymphomas.

Authors
RI Fisher;TP Miller;BW Dana;SE Jones;S Dahlberg;C Coltman, Jr
Journal / Conference
Seminars in Hematology 24(2):21-25
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508, SWOG-8516 (INT-0067)

Phase II evaluation of teniposide and ifosfamide in refractoryadult acute lymphocytic leukemia: A Southwest Oncology Group study.

Authors
DH Ryan;KJ Kopecky;D Head;CN Gumbart;MR Grever;C Karanes;JK Weick;C Coltman, Jr
Journal / Conference
Cancer Treat Rep 71(7-8):713-716
Year
1987
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8243, SWOG-8522

Mitotic counts in follicular lymphomas.

Authors
DJ Ellison;BN Nathwani;GE Metter;RR Turner;JS Burke;TP Miller;RB Mann;M Barcos;CR Kjeldsberg;CD Winberg;CC Whitcomb
Journal / Conference
Human Pathology 18:502-505
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427, SWOG-7713/14

Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.

Authors
FJ Mather;RM Simon;DD Von Hoff
Journal / Conference
Cancer Treat Rep 71(6):
Year
1987
Research Committee(s)
Breast, Genitourinary, and Lymphoma
Study Number(s)
SWOG-8203/04, SWOG-8517

Chemotherapy alone versus combined modality therapy for stage IIIhodgkin's disease: a five-year follow-up of a Southwest OncologyGroup study.

Journal / Conference
Third International Conference on Malignant Lymphoma-Lugano June 10-13
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7518

SWOG-8024: Combined modality therapy for disseminated softtissue sarcoma, phase III.

Authors
L Baker;S Green;J Ryan;B Rosenberg;S Balcerzak
Journal / Conference
ASCO :#C-542
Year
1987
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8024

Alternated and syncopated CHOP-CVB. A test of the Goldie-Coldmanhypothesis by the Southwest Oncology Group.

Authors
L Dabich;MK Liepman;AF LoBuglio;BK Schnitzer;S Dahlberg;PN Grozea;JW Athens;RP Pugh
Journal / Conference
ASCO :#C-810
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8112

Southwest Oncology Group (SWOG) trial: VM-26 and ifosfamide (IF)in refractory adult lymphocytic leukemia (ALL).

Authors
DH Ryan;KJ Kopecky;CH Gumbart;JN Bickers
Journal / Conference
ASCO :#C-561
Year
1987
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8243